FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

387294009: Neostigmine bromide (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1461472011 Neostigmine bromide (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1481395011 Neostigmine bromide en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
22191000188114 néostigmine bromure fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
827571000172119 bromure de néostigmine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Neostigmine bromide (substance) Is a Neostigmine (substance) false Inferred relationship Some
Neostigmine bromide (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Acetylcholine receptor agonist (disposition) false Inferred relationship Some
Neostigmine bromide (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Cholinesterase inhibitor false Inferred relationship Some
Neostigmine bromide (substance) Is a Reversible anticholinesterase true Inferred relationship Some
Neostigmine bromide (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Neostigmine (substance) true Inferred relationship Some
Neostigmine bromide (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Reversible anticholinesterase true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Neostigmine bromide 15 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Neostigmine bromide (substance) Inferred relationship Some
Product containing neostigmine bromide The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Neostigmine bromide (substance) Inferred relationship Some
Neostigmine bromide 15 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Neostigmine bromide (substance) Inferred relationship Some 1
Neostigmine bromide 15 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Neostigmine bromide (substance) Inferred relationship Some 1
Neostigmine 2.5mg/glycopyrronium 500mcg injection solution 1mL ampule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Neostigmine bromide (substance) Inferred relationship Some
Product containing glycopyrronium bromide and neostigmine bromide The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Neostigmine bromide (substance) Inferred relationship Some
Neostigmine bromide 15 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Neostigmine bromide (substance) Inferred relationship Some 1

Reference Sets

Description inactivation indicator reference set

GB English

US English

Back to Start